Interleukin-1 receptor antagonist as therapy for inflammatory disorders

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.1, Iss.2, 2001-03, pp. : 301-308

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Endogenous Interleukin-1 Receptor Antagonist is Neuroprotective

By Loddick S.A. Wong M.L. Bongiorno P.B. Gold P.W. Licinio J. Rothwell N.J.

Biochemical and Biophysical Research Communications, Vol. 234, Iss. 1, 1997-05 ,pp. : 211-215

Elsevier

Access to resources Recommend Favorite

Detection of an Interleukin-1 Intracellular Receptor Antagonist mRNA Variant

By Weissbach L. Tran K. Colquhoun S.A. Champliaud M.F. Towle C.A.

Biochemical and Biophysical Research Communications, Vol. 244, Iss. 1, 1998-03 ,pp. : 91-95

Elsevier

Access to resources Recommend Favorite

Expression of Interleukin-1β, Interleukin-1 Receptor, and Interleukin-1 Receptor Antagonist mRNA in Rat Carotid Artery after Balloon Angioplasty

By Wang X. Romanic A.M. Yue T-L. Feuerstein G.Z. Ohlstein E.H.

Biochemical and Biophysical Research Communications, Vol. 271, Iss. 1, 2000-04 ,pp. : 138-143

Elsevier

Access to resources Recommend Favorite

IL1HY1: A Novel Interleukin-1 Receptor Antagonist Gene

By Mulero J.J. Pace A.M. Nelken S.T. Loeb D.B. Correa T.R. Drmanac R. Ford J.E.

Biochemical and Biophysical Research Communications, Vol. 263, Iss. 3, 1999-10 ,pp. : 702-706

Elsevier

Access to resources Recommend Favorite

Interleukin-1β and receptor antagonist (IL-1Ra) gene polymorphisms and the prediction of the risk of end-stage renal disease

By Manchanda P. Kumar A. Bid H. Mittal R.

Biomarkers, Vol. 11, Iss. 2, 2006-03 ,pp. : 164-173

Informa Healthcare

Access to resources Recommend Favorite